Catalyst Wire Dossier Catalyst Wire Dossier

LJN452

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LJN452, covering 2019-05-01 to 2021-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis [Phase 2]

See pricing